Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed as antidiabetic agents, have emerged as candidate disease-modifying therapies for Parkinson’s disease (PD) and Alzheimer’s disease (AD), reflecting the widespread expression of GLP-1 receptors across neurons, glia, and the cerebral vasculature. This narrative review synthesizes mechanistic, clinical trial, and biomarker evidence for GLP-1 RAs in PD and AD, based on a literature search of PubMed, Embase, Scopus, and Web of Science, with ClinicalTrials.gov searched separately for trial protocols and results, through May 2026. Preclinical data implicate GLP-1 receptor agonism in anti-neuroinflammatory signaling, mitochondrial preservation, autophagy and proteostasis enhancement, anti-apoptotic effects, synaptic plasticity, cerebrovascular protection, and glymphatic clearance. Clinical evidence in PD is mixed and agent- and formulation-dependent: the phase II Exenatide-PD trial reported a motor benefit that persisted after washout (∼3.5-point between-group difference in MDS-UPDRS Part III), and the phase II LIXIPARK trial (lixisenatide) reported a significant 3.08-point between-group difference (95% CI 0.86–5.30; p = 0.007) favoring lixisenatide, whereas the larger, longer phase III Exenatide-PD3 trial, using an extended-release weekly formulation, found no significant effect on the same endpoint (adjusted coefficient 0.92; 95% CI −1.56 to 3.39; p = 0.47); oral semaglutide is under investigation in the ongoing phase II MOST-ABLE trial. In AD, the phase IIb liraglutide (ELAD) trial did not achieve statistical benefit on either its primary imaging endpoint (cerebral glucose metabolic rate; p = 0.14) or on most secondary cognitive measures, and the phase III semaglutide trials EVOKE and EVOKE+ did not meet their primary CDR-SB endpoint (estimated difference −0.08, 95% CI −0.35 to 0.20, p = 0.57 in EVOKE; 0.10, 95% CI −0.17 to 0.38, p = 0.46 in EVOKE+), despite biomarker signals including reductions in cerebrospinal fluid tau species and inflammatory markers. Comparative pharmacology reveals substantial heterogeneity in central nervous system penetration, receptor engagement, and systemic bioavailability across exenatide, liraglutide, semaglutide, and the imbalanced GLP-1/GIP co-agonist tirzepatide, complicating cross-agent extrapolation. Persistent challenges include separating direct neuroprotection from indirect metabolic and cardiovascular benefit, limited characterization of brain drug exposure, trial durations that may be short relative to the expected latency of a disease-modifying effect, and the absence of validated response biomarkers. We conclude that although the mechanistic and epidemiological rationale for GLP-1 RAs in neurodegeneration remains biologically plausible, current trial evidence does not yet support their use outside clinical trials, irrespective of comorbid diabetes status; future studies should prioritize earlier intervention, biomarker-guided patient selection, adequately powered subgroup analyses, and brain-penetrant formulations.
Avicenna Journal of Medicine · مجلد 16 (01) · 004-015
Globally, 1 in 10 children are impacted by war, with over 24,000 violations documented in 2020 alone. These children face persistent mental health challenges, including anxiety, depression, and posttraumatic stress disorder (PTSD). This systematic review evaluates current psychological interventions for war-affected children. Following PRISMA guidelines, 10 studies (2013-2021) from conflict zones in non-high-income countries were analyzed. Clinical interventions such as the Teaching Recovery Techniques (TRTs) are crucial; TRT is a low-cost intervention implementable by trained nonprofessionals under supervision. Findings revealed that TRT showed promise, especially when combined with parenting sessions, underscoring the importance of caregiver involvement. School-based programs were effective in addressing PTSD and anxiety symptoms, highlighting the key role of schools and trained teachers. Reading interventions improved affect recognition, and life-skills approaches enhanced social coping, but the most impactful strategies integrated caregivers. Successful interventions combined parental and community support, emphasizing cultural adaptation and individualized approaches for sustained mental health improvements.
war-affected childrenchild and adolescent mental healthpsychological interventionpost-traumatic stress disorder
Journal of the Saudi Heart Association · مجلد 37 (1) · 1-1
Objectives: The objective of this review is to evaluate the effectiveness of three-dimensional (3D) heart models as teaching tools for congenital heart disease (CHD), addressing the limitations of traditional medical education methods. Methods: A thorough literature review was conducted using PubMed, Google Scholar, Scientific Direct and Scopus databases. Relevant articles were screened and selected based on their discussion of the application of 3D models in CHD education. Results: The comprehensive review of 19 studies revealed that 3D heart models provide students, healthcare professionals, and patients with meaningful experiences that significantly enhance understanding and learning outcomes. These models improve objective knowledge, structural conceptualization, and personal satisfaction in medical education, especially in complex CHD compared to traditional methods such as books and 2D images (p < 0.001). Additionally, they enhance spatial orientation, surgical planning, simulation training, clinical reasoning, and critical thinking of healthcare providers. Patients and parents showed better comprehension and confidence in explaining their condition to others. Despite the cost and technical limitations, 3D models of CHD show promising potential. Conclusion: Integrating 3D heart models into CHD education has positively impacted knowledge acquisition, satisfaction, and confidence across various learner populations. The interactive and tangible nature of 3D models offers advantages over traditional teaching methods, fostering a deeper understanding of complex cardiac structures and pathology. However, further research is necessary to investigate long-term benefits and develop effective integration strategies in medical curricula and practice.
3D heart modelcongenital heart diseasemedical educationteaching aids